|
|
Neurology January 2009
Volume 72
Issue 4
| This Week in Neurology(R) |
this week in neurology(r): highlights of the january 27 issue.
Pages: 299
|
| Editorial |
idiopathic intracranial hypertension in men and the relationship to sleep apnea.
- Wall, Michael, Purvin, Valerie. Pages: 300-301
|
acgme, test thyself!
- Feske, Steven. Pages: 302-303
|
| Articles |
idiopathic intracranial hypertension in men symbol .
- Bruce, B, Kedar, S, Van Stavern, G, Monaghan, D, Acierno, M, Braswell, R, Preechawat, P, Corbett, J, Newman, N, Biousse, V. Pages: 304-309
>
Show/Hide Abstract
Objective: To compare the characteristics of idiopathic intracranial hypertension (IIH) in men vs women in a multicenter study.Methods: Medical records of all consecutive patients with definite IIH seen at three university hospitals were reviewed. Demographics, associated factors, and visual function at presentation and follow-up were collected. Patients were divided into two groups based on sex for statistical comparisons.Results: We included 721 consecutive patients, including 66 men (9%) and 655 women (91%). Men were more likely to have sleep apnea (24% vs 4%, p < 0.001) and were older (37 vs 28 years, p = 0.02). As their first symptom of IIH, men were less likely to report headache (55% vs 75%, p < 0.001) but more likely to report visual disturbances (35% vs 20%, p = 0.005). Men continued to have less headache (79% vs 89%, p = 0.01) at initial neuro-ophthalmologic assessment. Visual acuity and visual fields at presentation and last follow-up were significantly worse among men. The relative risk of severe visual loss for men compared with women was 2.1 (95% CI 1.4-3.3, p = 0.002) for at least one eye and 2.1 (95% CI 1.1-3.7, p = 0.03) for both eyes. Logistic regression supported sex as an independent risk factor for severe visual loss.Conclusion: Men with idiopathic intracranial hypertension (IIH) are twice as likely as women to develop severe visual loss. Men and women have different symptom profiles, which could represent differences in symptom expression or symptom thresholds between the sexes. Men with IIH likely need to be followed more closely regarding visual function because they may not reliably experience or report other symptoms of increased intracranial pressure.(C)2009AAN Enterprises, Inc.
|
mutations in gba are associated with familial parkinson disease susceptibility and age at onset.
- Nichols, W, Pankratz, N, Marek, D, Pauciulo, M, Elsaesser, V, Halter, C, Rudolph, A, Wojcieszek, J, Pfeiffer, R, Foroud, T. Pages: 310-316
>
Show/Hide Abstract
Objective: To characterize sequence variation within the glucocerebrosidase (GBA) gene in a select subset of our sample of patients with familial Parkinson disease (PD) and then to test in our full sample whether these sequence variants increased the risk for PD and were associated with an earlier onset of disease.Methods: We performed a comprehensive study of all GBA exons in one patient with PD from each of 96 PD families, selected based on the family-specific lod scores at the GBA locus. Identified GBA variants were subsequently screened in all 1325 PD cases from 566 multiplex PD families and in 359 controls.Results: Nine different GBA variants, five previously reported, were identified in 21 of the 96 PD cases sequenced. Screening for these variants in the full sample identified 161 variant carriers (12.2%) in 99 different PD families. An unbiased estimate of the frequency of the five previously reported GBA variants in the familial PD sample was 12.6% and in the control sample was 5.3% (odds ratio 2.6; 95% confidence interval 1.5-4.4). Presence of a GBA variant was associated with an earlier age at onset (p = 0.0001). On average, those patients carrying a GBA variant had onset with PD 6.04 years earlier than those without a GBA variant.Conclusions: This study suggests that GBA is a susceptibility gene for familial Parkinson disease (PD) and patients with GBA variants have an earlier age at onset than patients with PD without GBA variants.(C)2009AAN Enterprises, Inc.
|
effect of aerobic training in patients with spinal and bulbar muscular atrophy (kennedy disease).
- Preisler, N, Andersen, G, Thogersen, F, Crone, C, MD, PhD, Jeppesen, T, Wibrand, F, Vissing, J, MD, PhD. Pages: 317-323
>
Show/Hide Abstract
Objective: We examined the effect of aerobic exercise in patients with spinal and bulbar muscular atrophy (SBMA). SBMA is caused by a defect androgen receptor. This defect causes motor neuron death, but considering the important function of androgens in muscle, it is possible that muscle damage in SBMA also occurs independently of motor neuron damage.Methods: Eight patients with SBMA engaged in regular cycling exercise for 12 weeks. Maximum oxygen uptake (Vo2max), maximal work capacity (Wmax), muscle morphology, citrate synthase (CS) activity, body composition, EMG, static strength measurements, lung function, plasma proteins, and hormones were evaluated before and after training. Evaluation of improvements in activities of daily living (ADL) was conducted after training.Results: Wmax increased by 18%, and CS activity increased by 35%. There was no significant change in Vo2max or any of the other variables examined before and after training, and the patients with SBMA did not feel improvements in ADL.Conclusions: Frequent, moderate-intensity aerobic conditioning is of little beneficial effect in patients with spinal and bulbar muscular atrophy (SBMA). High levels of plasma creatine kinase and muscle regeneration indicate a primary myopathic affection, which, in parallel with the motor neuron deficiency, may attenuate the response to exercise training in patients with SBMA.(C)2009AAN Enterprises, Inc.
|
comparing explorative saccade and flicker training in hemianopia: a randomized controlled study.
- Roth, T, Sokolov, A, Messias, A, Roth, P, Weller, M, Trauzettel-Klosinski, S. Pages: 324-331
>
Show/Hide Abstract
Objective: Patients with homonymous hemianopia are disabled on everyday exploratory activities. We examined whether explorative saccade training (EST), compared with flicker-stimulation training (FT), would selectively improve saccadic behavior on the patients' blind side and benefit performance on natural exploratory tasks.Methods: Twenty-eight hemianopic patients were randomly assigned to distinct groups performing for 6 weeks either EST (a digit-search task) or FT (blind-hemifield stimulation by flickering letters). Outcome variables (response times [RTs] during natural search, number of fixations during natural scene exploration, fixation stability, visual fields, and quality-of-life scores) were collected before, directly after, and 6 weeks after training.Results: EST yielded a reduced (post/pre, 47%) digit-search RT for the blind side. Natural search RT decreased (post/pre, 23%) on the blind side but not on the seeing side. After FT, both sides' RT remained unchanged. Only with EST did the number of fixations during natural scene exploration increase toward the blind and decrease on the seeing side (follow-up/pre difference, 238%). Even with the target located on the seeing side, after EST more fixations occurred toward the blind side. The EST group showed decreased (post/pre, 43%) fixation stability and increased (post/pre, 482%) asymmetry of fixations toward the blind side. Visual field size remained constant after both treatments. EST patients reported improvements in social domain.Conclusions: Explorative saccade training selectively improves saccadic behavior, natural search, and scene exploration on the blind side. Flicker-stimulation training does not improve saccadic behavior or visual fields. The findings show substantial benefits of compensatory exploration training, including subjective improvements in mastering daily-life activities, in a randomized controlled trial.(C)2009AAN Enterprises, Inc.
|
tp53 codon 72 polymorphism is associated with age at onset of glioblastoma.
- Hallani, S, Ducray, F, Idbaih, A, MD, PhD, Marie, Y, Boisselier, B, Colin, C, Laigle-Donadey, F, Rodero, M, Chinot, O, Thillet, J, Hoang-Xuan, K, MD, PhD, Delattre, J-Y, Sanson, M, MD, PhD. Pages: 332-336
>
Show/Hide Abstract
Background: Functional single nucleotide polymorphisms (SNP) in codon 72 of TP53 have been shown to be a risk factor, a prognostic marker, and related factor to age at onset in various cancers.Methods: We investigated blood samples from 254 patients with glioblastoma and 238 healthy controls.Results: TP53 codon 72 status was not correlated with prognosis and did not differ between glioblastoma and control populations. However, the Pro/Pro genotype was overrepresented in patients <45 years (20.6% vs 6.4% in patients with glioblastoma >45 years, p = 0.002, vs 5.9% in control group, p = 0.001). We then confirmed this result on an independent series of young patients with glioblastoma. Finally, the analysis of tumor DNA found the Pro allele associated with occurrence of TP53 somatic mutation.Conclusion: Our data suggest that TP53 functional variation is particularly critical for oncogenesis of glioblastoma in young patients.(C)2009AAN Enterprises, Inc.
|
treatment of cns sarcoidosis with infliximab and mycophenolate mofetil.
- Moravan, Michael, Segal, Benjamin. Pages: 337-340
>
Show/Hide Abstract
Objective: To describe the effects of the anti-tumor necrosis factor neutralizing antibody, infliximab, and the antiproliferative immunosuppressant, mycophenolate mofetil, in refractory neurosarcoidosis.Methods: We treated patients with biopsy-proven sarcoidosis and CNS involvement, who had failed treatment with steroids, with infliximab (5 mg/kg on weeks 0, 2, and 6, and then every 6-8 weeks thereafter). Six out of seven patients were co-treated with mycophenolate mofetil (1,000 mg PO BID). Patients underwent a review of symptoms and complete neurologic examination every 3 months and MRI scanning before and after 3-4 infusions of infliximab.Results: All patients reported significant symptomatic improvement by the fourth infusion of infliximab, including relief of headache and neuropathic pain, reversal of motor, sensory, or coordination deficits, and control of seizure activity. Furthermore, infliximab therapy was universally associated with a decrease in lesion size or suppression of gadolinium enhancement as documented by MRI. A positive treatment response was attained irrespective of location or distribution of CNS involvement by sarcoidosis (dural/leptomeningeal based vs intraparenchymal; cord vs brain; single lesion vs multifocal). There were no serious adverse effects in a follow-up period spanning 6-18 months.Conclusions: Combination treatment with mycophenolate mofetil and infliximab is a promising therapeutic approach for neurosarcoidosis.GLOSSARY: A = azathioprine; AA = African American; Cy = cyclophosphamide; E = etanercept; EDSS = Expanded Disability Status Scale; MMF = mycophenolate mofetil; MMSE = Mini-Mental State Examination; N = neurologic; O = ophthalmologic; P = pulmonary; Pq = Plaquenil; R = rheumatologic; Si = sinuses; S = steroids; TNF = tumor necrosis factor; VPS = ventriculoperitoneal shunt; W = white.(C)2009AAN Enterprises, Inc.
|
treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients.
- Burns, Brian, Watkins, Laurence, Goadsby, Peter, MD, PhD. Pages: 341-345
>
Show/Hide Abstract
Background: Cluster headache is a primary headache involving repeated attacks of excruciatingly severe headache usually occurring several times a day. Most patients with chronic cluster headache (CCH) have an unremitting illness requiring daily preventive therapy for years.Objective: To describe the clinical outcome of occipital nerve stimulation (ONS) for 14 patients with intractable CCH.Methods: Fourteen patients with medically intractable CCH were implanted with bilateral electrodes in the suboccipital region for ONS and a retrospective assessment of their clinical outcome obtained.Results: At a median follow-up of 17.5 months (range 4-35 months), 10 of 14 patients reported improvement and 9 of these recommend ONS. Three patients noticed a marked improvement of 90% or better (90%, 90%, and 95%), 3 a moderate improvement of 40% or better (40%, 50%, and 60%), and 4 a mild improvement of 20-30% (20%, 20%, 25%, and 30%). Improvement occurred within days to weeks for those who responded most and patients consistently reported their attacks returned within hours to days when the device was off. One patient found that ONS helped abort acute attacks. Adverse events of concern were lead migrations and battery depletion.Conclusion: Intractable chronic cluster headache (CCH) is a devastating, disabling condition that has traditionally been treated with cranially invasive or neurally destructive procedures. ONS offers a safe, effective option for some patients with CCH. More work is required to evaluate and understand this novel therapy.GLOSSARY: CCH = chronic cluster headache; DBS = deep brain stimulation; DHE = dihydroergotamine; ONS = occipital nerve stimulation.(C)2009AAN Enterprises, Inc.
|
epidemiology of ischemic stroke from atrial fibrillation in dijon, france, from 1985 to 2006.
- Bejot, Y, Salem, D, Osseby, G, Couvreur, G, Durier, J, Marie, C, Cottin, Y, Moreau, T, Giroud, M. Pages: 346-353
>
Show/Hide Abstract
Background: Atrial fibrillation (AF) is strongly associated with age, and epidemiologic studies are needed to evaluate the impact of both aging of the population and the use of anticoagulant therapy in patients with AF on the incidence of cardioembolic stroke with AF (CE/AF stroke).Methods: We evaluated trends in incidence rates, risk factors, prestroke therapy, and survival in CE/AF stroke from a prospective population-based registry, from 1985 to 2006.Results: A total of 3,064 ischemic strokes, including 572 (18.7%) CE/AF strokes, were recorded. Over the 22 years, a decrease in the incidence of overall CE/AF stroke was noted (incidence rate ratio 0.9858, 95% confidence interval [CI] 0.9731-0.9986; p = 0.03). We observed a higher prevalence of previous AF, previous myocardial infarction, and patients aged >70 years in CE/AF stroke (p < 0.0001) whereas hypercholesterolemia was more prevalent in other ischemic strokes (p = 0.003). A significant increase in the use of anticoagulants and antiplatelet agents was noted, and was particularly pronounced for CE/AF stroke with previous AF. For CE/AF stroke, survival rates were 72% at 1 month (95% CI 0.68-0.76), 52% at 1 year (95% CI 0.48-0.56), and 43% at 2 years (95% CI 0.39-0.48), and remained lower than those of other ischemic stroke.Conclusions: The decrease in the incidence of cardioembolic/atrial fibrillation stroke in our study was probably due to a slight increase in the utilization of antithrombotic therapy in patients with atrial fibrillation, but the use of such therapies will have to increase further because of the expected aging of the population in coming years.GLOSSARY: AF = atrial fibrillation; CE = cardioembolic; CI = confidence interval; IRR = incidence rate ratios.(C)2009AAN Enterprises, Inc.
|
factors associated with resistance to dementia despite high alzheimer disease pathology.
- Erten-Lyons, D, Woltjer, R, Dodge, H, Nixon, R, Vorobik, R, Calvert, J, Leahy, M, Montine, T, Kaye, J. Pages: 354-360
>
Show/Hide Abstract
Background: Autopsy series have shown that some elderly people remain with normal cognitive function during life despite having high burdens of pathologic lesions associated with Alzheimer disease (AD) at death. Understanding why these individuals show no cognitive decline, despite high AD pathologic burdens, may be key to discovery of neuroprotective mechanisms.Methods: A total of 36 subjects who on autopsy had Braak stage V or VI and moderate or frequent neuritic plaque scores based on Consortium to Establish a Registry for Alzheimer's Disease (CERAD) standards were included. Twelve had normal cognitive function and 24 a diagnosis of AD before death. Demographic characteristics, clinical and pathologic data, as well as antemortem brain volumes were compared between the groups.Results: In multiple regression analysis, antemortem hippocampal and total brain volumes were significantly larger in the group with normal cognitive function after adjusting for gender, age at MRI, time from MRI to death, Braak stage, CERAD neuritic plaque score, and overall presence of vascular disease.Conclusion: Larger brain and hippocampal volumes were associated with preserved cognitive function during life despite a high burden of Alzheimer disease (AD) pathologic lesions at death. A better understanding of processes that lead to preservation of brain volume may provide important clues for the discovery of mechanisms that protect the elderly from AD.GLOSSARY: AD = Alzheimer disease; CDR = Clinical Dementia Rating Scale; CERAD = Consortium to Establish a Registry for Alzheimer's Disease; CIRS = Cumulative Illness Rating Scale; ICV = intracranial volume; LB = Lewy bodies; MMSE = Mini-Mental State Examination; NCSE = Neurobehavioral Cognitive Status Examination; NFT = neurofibrillary tangle; NIA = National Institute on Aging; NP = neuritic plaques; OHSU = Oregon Health & Science University; Ref = reference; SES = socioeconomic status; UPDRS = Unified Parkinson's Disease Rating Scale.(C)2009AAN Enterprises, Inc.
|
biochemical indicators of vitamin b12 and folate insufficiency and cognitive decline.
- Tangney, Christine, Tang, Yuxiao, Evans, Denis, Morris, Martha. Pages: 361-367
>
Show/Hide Abstract
Background: In some prospective studies, associations of serum vitamin B12 and homocysteine concentrations with cognitive decline have been reported but few have examined the role of methylmalonic acid, a more specific marker of vitamin B12 deficiency than homocysteine.Objective: The aim of the study was to determine whether serum concentrations of vitamin B12 or selected metabolites are related to cognitive decline.Methods: A total of 516 subjects were selected in a stratified random sampling design from among Chicago Health and Aging Project participants for clinical evaluation. We used linear mixed models to examine the association of blood markers of vitamin B12 status to change in cognitive scores over 6 years. Cognitive function was assessed every 3 years and measured as the sum of standardized scores on four tests.Results: Probable vitamin B12 deficiency was observed in 14.2% of the sample. Elevated serum concentrations of homocysteine were present in 19.2% of subjects, and of methylmalonic acid, in 36.4%. Higher serum methylmalonic acid concentrations were predictive of faster rates of cognitive decline ([beta] = -0.00016, SE = 0.0001, p = 0.004) and higher serum vitamin B12 concentrations were associated with slower rates of cognitive decline ([beta] = +0.00013, SE < 0.0001, p = 0.005) in multivariable adjusted mixed models. Serum concentrations of homocysteine had no relationship to cognitive decline.Conclusions: Serum methylmalonic acid and vitamin B12 concentrations may be the more important risk factors for cognitive decline when compared to serum homocysteine concentrations, particularly in older populations exposed to food fortification and possible supplements containing folic acid.GLOSSARY: CHAP = Chicago Health and Aging Project; CI = confidence interval; FFQ = food frequency questionnaire; NHANES = National Health and Nutrition Examination Survey; OR = odds ratio.(C)2009AAN Enterprises, Inc.
|
| Views & Reviews |
vascular risk factors and dementia: how to move forward?
- Viswanathan, Anand, MD, PhD, Rocca, Walter, MD, MPH, Tzourio, Christophe, MD, PhD. Pages: 368-374
>
Show/Hide Abstract
In recent years, accumulating evidence has suggested that vascular risk factors contribute to Alzheimer disease (AD). Vascular dementia had been traditionally considered secondary to stroke and vascular disease. It has been traditionally distinguished from AD, considered to be a purely neurodegenerative form of dementia. However, in light of this more recent literature, it appears that there is a spectrum: ranging from patients with pure vascular dementia to patients with pure AD and including a large majority of patients with contributions from both Alzheimer and vascular pathologies. In this article, we discuss the impact of vascular risk factors on AD and its consequences at the individual level and at the population level by highlighting the concept of attributable risk. We then discuss the key questions and next steps involved in designing a therapeutic trial to control vascular risk factors for the prevention of dementia.(C)2009AAN Enterprises, Inc.
|
| Clinical/Scientific Notes |
novel fhl1 mutations in fatal and benign reducing body myopathy.
- Shalaby, S, Hayashi, Y, MD, PhD, Nonaka, I, MD, PhD, Noguchi, S, Nishino, I, MD, PhD. Pages: 375-376
|
elemental mercury neurotoxicity from self-injection.
- Schaumburg, H, Gellido, C, Smith, S, Nelson, L, Hoffman, R. Pages: 377-378
|
linezolid inducing complex partial status epilepticus in a patient with epilepsy.
- Shneker, Bassel, Baylin, Peggy, Nakhla, Michael. Pages: 378-379
|
| Reflections: Neurology and the Humanities |
poems.
- Ginsberg, Arthur. Pages: 380
|
| NeuroImages |
open-ring peripherally enhancing lesion of the cervical spine.
- Pyle, Wilson, Dastur, Khurshed, Rahman, Moshin, Tsay, Jawad. Pages: 381
|
| Resident & Fellow Section |
education research: neurology residency training in the new millennium.
- Schuh, L, Adair, J, Drogan, O, Kissela, B, Morgenlander, J, Corboy, J. Pages: e15-e20
>
Show/Hide Abstract
Objective: To survey adult neurology program directors (ANPD) to identify their most pressing needs at a time of dramatic change in neurology resident education.Methods: All US ANPD were surveyed in 2007 using an instrument adjusted from a 1999 survey instrument. The goal was to characterize current program content, the institution and evaluation of the core competencies, program director characteristics, program director support, the institution of work duty hour requirements, resident support, and the curriculum needs of program directors and programs.Results: A response rate of 82.9% was obtained. There is a significant disconnect between administration time spent by ANPD and departmental/institutional support of this, with ANPD spending approximately 35% of a 50-hour week on administration with only 16.7% salary support. Rearrangement of rotations or services has been the most common mode for ANPD to deal with work duty hour requirements, with few programs employing mid level providers. Most ANPD do not feel work duty hour reform has improved resident education. More residents are entering fellowships following graduation than documented in the past. Curriculum deficiencies still exist for ANPD to meet all Neurology Program Requirements, especially for nontraditional neurology topics outside the conventional bounds of clinical neurology (e.g., practice management). Nearly one quarter of neurology residency programs do not have a meeting or book fund for every resident in the program.Conclusions: Adult neurology program directors (ANPDs) face multiple important financial and organizational hurdles. At a time of increasing complexity in medical education, ANPDs need more institutional support.(C)2009AAN Enterprises, Inc.
|
| Patient Page |
alzheimer disease: what changes in the brain cause dementia?
- Welsh-Bohmer, Kathleen, White, Charles. Pages: e21
|
| Correspondence |
practice parameter: assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology.
- Friedman, Joseph. Pages: 382-383
|
a randomized, placebo-controlled trial of repeated iv antibiotic therapy for lyme encephalopathy prolonged lyme disease treatment: enough is enough.
- Marques, A, Shaw, P, Schmid, C, Steere, A, Kaplan, R, Hassett, A, Shapiro, E, Wormser, G. Pages: 383-386
|
| Departments: Book Review |
the fatal sleep: africa's killer disease that went undiscovered for centuries.
- Gilden, Donald. Pages: 387
|
| Departments: Calendar |
calendar.
Pages: 388
|
| Future Issues |
in the next issue of neurology(r): volume 72, number 5, february 3, 2009.
Pages: A38
|
|
|